C. Fletcher, J. Bridge, and P. Hogendoorn, WHO Classification of tumors of soft tissue and bone 4th edition. Lyon: IARC, 2013.

J. M. Mosquera, A. Sboner, and L. Zhang, Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma, Genes Chromosomes Cancer, vol.52, pp.538-50, 2013.

R. Alaggio, L. Zhang, and Y. Sung, A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases, Am J Surg Pathol, vol.40, pp.224-259, 2016.

S. Watson, V. Perrin, and D. Guillemot, Transcriptomic definition of molecular subgroups of small round cell sarcomas, J Pathol, vol.245, pp.29-40, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02440510

N. P. Agaram, C. Chen, and L. Zhang, Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis, Genes Chromosomes Cancer, vol.53, pp.779-87, 2014.

S. Kohsaka, N. Shukla, and N. Ameur, A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations, Nat Genet, vol.46, pp.595-600, 2014.

B. Rekhi, P. Upadhyay, and M. P. Ramteke, MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes, Mod Pathol, vol.29, pp.1532-1572, 2016.

N. P. Agaram, M. P. Laquaglia, and R. Alaggio, MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification, Mod Pathol, vol.32, pp.27-36, 2019.

L. Loarer, F. Cleven, A. Bouvier, and C. , A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation, Mod Pathol, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02440660

N. P. Agaram, L. Zhang, and Y. Sung, Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype, Am J Surg Pathol, vol.43, pp.695-702, 2019.

A. P. Martinez, K. J. Fritchie, and S. W. Weiss, Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms, Mod Pathol, vol.32, pp.446-457, 2019.

H. Ge, K. Liu, T. Juan, and F. Fang, FusionMap: detecting fusion genes from nextgeneration sequencing data at base-pair resolution, Bioinforma Oxf Engl, vol.15, pp.1922-1930, 2011.

B. Haas, A. Dobin, and N. Stransky, STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq, p.120295, 2017.

D. S. Nicorici, H. Edgren, and S. Kangaspeska, FusionCatcher -a tool for finding somatic fusion genes in paired-end RNA-sequencing data, p.11650, 2014.

M. Benelli, C. Pescucci, and G. Marseglia, Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript, Bioinforma Oxf Engl, vol.28, pp.3232-3241, 2012.

N. L. Bray, H. Pimentel, and P. Melsted, Near-optimal probabilistic RNA-seq quantification, Nat Biotechnol, vol.34, pp.525-532, 2016.

, Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2017.

A. Subramanian, P. Tamayo, and V. K. Mootha, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci, vol.102, pp.15545-50, 2005.

M. Laé, E. H. Ahn, and G. E. Mercado, Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas, J Pathol, vol.212, pp.143-51, 2007.

D. Williamson, E. Missiaglia, and A. De-reyniès, Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma, J Clin Oncol, vol.28, pp.2151-2159, 2010.

G. Choi, J. Li, Y. Wang, and L. Li, The Metalloprotease ADAMTS8 Displays Antitumor Properties through Antagonizing EGFR-MEK-ERK Signaling and Is Silenced in Carcinomas by CpG Methylation, Mol Cancer Res, vol.12, pp.228-266, 2014.

M. Urbini, A. Astolfi, V. Indio, and G. Tarantino, Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue, Oncotarget, vol.8, pp.60036-60081, 2017.

G. Pipes, E. E. Creemers, and E. N. Olson, The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis, Genes Dev, vol.20, pp.1545-56, 2006.

D. Coletti, N. Daou, and M. Hassani, Serum Response Factor in Muscle Tissues: From Development to Ageing, Eur J Transl Myol, vol.26, p.6008, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01545731

S. Li, M. P. Czubryt, and J. Mcanally, Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice, Proc Natl Acad Sci, vol.102, pp.1082-1089, 2005.

M. Wachtel, M. Dettling, and E. Koscielniak, Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1, Cancer Res, vol.64, pp.5539-5584, 2004.

J. Sumegi, R. Streblow, and R. W. Frayer, Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family, Genes Chromosomes Cancer, vol.49, pp.224-260, 2010.

S. Huang, R. A. Ghossein, J. A. Bishop, and Z. , Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation, Am J Surg Pathol, vol.40, pp.51-60, 2016.

S. Andreasen, J. A. Bishop, and H. Hellquist, Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity, Virchows Arch Int J Pathol, vol.473, pp.615-641, 2018.

C. Leo and J. D. Chen, The SRC family of nuclear receptor coactivators, Gene, vol.245, pp.1-11, 2000.

J. Xu, R. Wu, O. Malley, and B. W. , Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family, Nat Rev Cancer, vol.9, pp.615-645, 2009.

J. Xu and Q. Li, Review of the in vivo functions of the p160 steroid receptor coactivator family, Mol Endocrinol Baltim Md, vol.17, pp.1681-92, 2003.

E. C. Douglass, M. Valentine, and E. Etcubanas, A specific chromosomal abnormality in rhabdomyosarcoma, Cytogenet Cell Genet, vol.45, pp.148-55, 1987.

C. Turc-carel, S. Lizard-nacol, and E. Justrabo, Consistent chromosomal translocation in alveolar rhabdomyosarcoma, Cancer Genet Cytogenet, vol.19, pp.361-363, 1986.

S. Wang-wuu, S. Soukup, and E. Ballard, Chromosomal analysis of sixteen human rhabdomyosarcomas, Cancer Res, vol.48, pp.983-990, 1988.

F. G. Barr, Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma, Oncogene, vol.20, pp.5736-5782, 2001.

M. Xu, X. Chen, and D. Chen, FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification, Oncotarget, vol.8, pp.10662-74, 2017.